LexDanaLexDanabeta
Inventor

Robertus Cornelis ROOVERS

Inventor
NL

Overview

4→
Patents
2023–2025
Patent span
Human necessities
Primary field (CPC A)

Patents· 4 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations36%
C07KPeptides36%
A61KPreparations for medical, dental or toiletry purposes27%
PatentTitleYear
12,428,493Antibodies that bind PSMA and gamma-delta T cell receptors202512,325,746Bispecific antibody202511,820,825Methods of treating a subject having an EGFR-positive and/or ErbB-3-positive tumor202311,773,170Antibodies that bind EGFR and cMET2023

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2023Patents assigned to MERUS NV (2)· patent assignee history
2023–2025Based in NL· patent location history
2025Patents assigned to LAVA THERAPEUTICS N V (1)· patent assignee history
2025Patents assigned to ONO PHARMACEUTICAL CO (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
MERUS NV22023
LAVA THERAPEUTICS N V12025
ONO PHARMACEUTICAL CO12025
Locations
LocationPatentsSpan
NL42023–2025